DOI QR코드

DOI QR Code

Carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone-induced toxicities in rats: comparative study with other mitochondrial uncouplers (2,4-dinitrophenol, OPC-163493 and tolcapone)

  • Yuki Inoue (Department of Drug Safety Research, Nonclinical Research Center, Tokushima Research Institute) ;
  • Yuko Wada (PV Operation, Pharmacovigilance Department, Otsuka Pharmaceutical Co., Ltd.) ;
  • Makoto Sato (Department of Drug Safety Research, Nonclinical Research Center, Tokushima Research Institute) ;
  • Seiji Sato (Medicinal Chemistry Research Laboratories, New Drug Research Division, Otsuka Pharmaceutical Co., Ltd.) ;
  • Takashi Okamoto (Department of Lead Discovery Research, New Drug Research Division, Otsuka Pharmaceutical Co., Ltd.) ;
  • Naohide Kanemoto (Department of Drug Discovery Strategy, Osaka Research Center for Drug Discovery, Otsuka Pharmaceutical Co., Ltd.)
  • Received : 2022.12.18
  • Accepted : 2023.05.04
  • Published : 2023.10.15

Abstract

FCCP (carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone) is known to inhibit oxidative phosphorylation as a protonophore, dissipating the proton gradient across the inner mitochondrial membrane. To understand the toxicity of FCCP, 3-day, 2- and 4-week repeated oral dose studies were performed in male rats. In the 3-day and 2-week repeated dose toxicity studies, observations included salivation, increased body temperature, and dead and moribund animals. Increased liver weight was observed in conjunction with hydropic degeneration and centrilobular necrosis of hepatocytes. In addition, pathological changes were observed in the pancreas, testis, epididymal duct, stomach and parotid gland. Electron microscopic examination revealed mitochondrial pleomorphism in the hepatocytes. Swelling of mitochondria was observed in the alpha cells and beta cells of the pancreas. Dilatation of rough endoplasmic reticulum, Golgi bodies and loss of secretory granules were also noted in the beta cells of the pancreas. FCCP was also compared with three other mUncouplers (DNP, OPC-163493 and tolcapone) with regard to in vitro mitochondrial uncoupling (mUncoupling) activities. FCCP produced the peak ΔOCR (oxygen consumption rate) at the lowest concentration (0.4 μM), followed by OPC-163493, tolcapone, and DNP, based on peak values in ascending order of concentration (2.5, 10, and 50 μM, respectively). Considering the relationship between the mUncoupling activity and toxicity profile of the four mUncouplers, there is no parallel relationship between the in vitro mUncoupling activity and the degree of in vivo toxicity. These findings may contribute to the efficient development of new mitochondrial uncoupler candidates.

Keywords

Acknowledgement

The authors are grateful to Eiji Kashiyama and Ken Umehara for recommending the submission of this article.

References

  1. Satcher D (1995) Toxicological profile for dinitrophenols. U.S. Department of Health and Human Services, Agency for Toxic Substances and Disease Registry, Atlanta 
  2. Cunha FM, Caldeira da Silva CC, Cerqueira FM, Kowaltowski AJ (2011) Mild mitochondrial uncoupling as a therapeutic strategy. Curr Drug Targets 12:783-789. https://doi.org/10.2174/138945011795528778 
  3. Jastroch M, Keipert S, Perocchi F (2014) From explosives to physiological combustion: next generation chemical uncouplers. Mol Metab 3:86-87. https://doi.org/10.1016/j.molmet.2014.01.003 
  4. Fu YY, Zhang M, Turner N, Zhang LN, Dong TC, Gu M, Leslie SJ, Li JY, Nan FJ, Li J (2013) A novel chemical uncoupler ameliorates obesity and related phenotypes in mice with diet-induced obesity by modulating energy expenditure and food intake. Diabetologia 56:2297-2307. https://doi.org/10.1007/s00125-013-2987-9 
  5. Kenwood BM, Weaver JL, Bajwa A, Poon IK, Byrne FL, Murrow BA, Calderone JA, Huang L, Divakaruni AS, Tomsig JL, Okabe K, Lo RH, Cameron Coleman G, Columbus L, Yan Z, Saucerman JJ, Smith JS, Holmes JW, Lynch KR, Ravichandran KS, Uchiyama S, Santos WL, Rogers GW, Okusa MD, Bayliss DA, Hoehn KL (2013) Identification of a novel mitochondrial uncoupler that does not depolarize the plasma membrane. Mol Metab 3:114-123. https://doi.org/10.1016/j.molmet.2013.11.005 
  6. Perry RJ, Kim T, Zhang XM, Lee HY, Pesta D, Popov VB, Zhang D, Rahimi Y, Jurczak MJ, Cline GW, Spiegel DA, Shulman GI (2013) Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler. Cell Metab 18:740-748. https://doi.org/10.1016/j.cmet.2013.10.004 
  7. Perry RJ et al (2015) Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats. Science 347:1253-1256. https://doi.org/10.1126/science.aaa0672 
  8. Tao H et al (2014) Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice. Nat Med 20:1263-1269. https://doi.org/10.1038/nm.3699 
  9. Kanemoto N et al (2019) Antidiabetic and cardiovascular beneficial effects of a liver-localized mitochondrial uncoupler. Nat Commun 10:2172. https://doi.org/10.1038/s41467-019-09911-6 
  10. Okamoto T et al (2021) New approach to drug discovery of a safe mitochondrial uncoupler: OPC-163493. ACS Omega 6:16980-16988. https://doi.org/10.1021/acsomega.1c0199 
  11. Inoue Y et al (2022) Preclinical safety profile of a liver-localized mitochondrial uncoupler: OPC-163493. EXCLI J 21:213-235. https://doi.org/10.17179/excli2021-4414 
  12. Haasio K et al (2001) Comparative toxicological study on the hepatic safety of entacapone and tolcapone in the rat. J Neural Transm 108:79-91. https://doi.org/10.1007/s007020170099 
  13. Fabbri M et al (2022) COMT inhibitors in the management of Parkinson's disease. CNS Drugs 36:261-282. https://doi.org/10.1007/s40263-021-00888-9 
  14. Haasio K et al (2002) Effects of entacapone and tolcapone on mitochondrial membrane potential. Eur J Pharmacol 453:21-26. https://doi.org/10.1016/s0014-2999(02)02383-x 
  15. Heytler PG, Prichard WW (1962) A new class of uncoupling agents-carbonyl cyanide phenylhydrazones. Biochem Biophys Res Commun 7:272-275. https://doi.org/10.1016/0076-6879(79)55060-5 
  16. Heytler PG (1979) Uncouplers of oxidative phosphorylation. Methods Enzymol 55:462-472  https://doi.org/10.1016/0076-6879(79)55060-5
  17. Park KS (2002) FCCP depolarizes plasma membrane potential by activating proton and Na+ currents in bovine aortic endothelial cells. Pflugers Arch 443:344-352. https://doi.org/10.1007/s004240100703 
  18. Georgakopoulos ND, Wells G, Campanella M (2017) The pharmacological regulation of cellular mitophagy. Nat Chem Biol 13:136-146. https://doi.org/10.1038/nchembio.2287 
  19. Kane MS et al (2018) Current mechanistic insights into the CCCP-induced cell survival response. Biochem Pharmacol 148:100-110. https://doi.org/10.1016/j.bcp.2017.12.018 
  20. Wu M et al (2007) Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am J Physiol Cell Physiol 292:125-136. https://doi.org/10.1152/ajpcell.00247.2006 
  21. Mythili MD et al (2004) Effect of streptozotocin on the ultrastructure of rat pancreatic islets. Micro Res Tech 63:274-278. https://doi.org/10.1002/jemt.20039 
  22. Szkudelski T (2001) The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50:537-546 
  23. Maronpot RR, Boorman GA, Gaul BW (1999) Liver and gallbladder. In: Pathology of the mouse. Cache River Press, pp 119-183 
  24. Peiris LDC et al (2019) 1,3-Dinitrobenze-induced genotoxicity through altering nuclear integrity of diploid and polyploidy germ cells. Dose Response. https://doi.org/10.1177/1559325819876760 
  25. Li Y et al (2014) Scrotal heat induced the Nrf2-driven antioxidant response during oxidative stress and apoptosis in the mouse testis. Acta Histochem 116:883-890. https://doi.org/10.1016/j.acthis.2014.02.008 
  26. Kheradmand A, Dezfoulian O, Alirezaei M (2012) Ghrelin regulates Bax and PCNA but not Bcl-2 expressions following scrotal hyperthermia in the rat. Tissue Cell 44:308-315. https://doi.org/10.1016/j.tice.2012.04.009 
  27. Everds NE et al (2013) Interpreting stress responses during routine toxicity studies: a review of the biology, impact, and assessment. Toxicol Pathol 41:560-614. https://doi.org/10.1177/0192623312466452 
  28. Haasio K et al (2002) Different toxicological profile of two COMT inhibitors in vivo: the role of uncoupling effects. J Neural Transm 109:1391-1401. https://doi.org/10.1007/s00702-002-0748-x 
  29. Male rats treated orally with 2,4-dinitrophenol in the 28-day repeat dose toxicity test [online]. Research Institute for Animal Science in Biochemistry and Toxicology. https://dra4.nihs.go.jp/mhlw_data/home/pdf/PDF51-28-5b.pdf [Figures and Tables in English] 
  30. Tolcapone, pharmacology review part 1 [online]. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20697_Tasmar_pharmr_P1.pdf